Atossa Therapeutics
ATOS
#10608
Rank
S$30.22 M
Marketcap
S$3.03
Share price
-2.07%
Change (1 day)
199.09%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -S$48.28 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$44.46 Million a decrease over its 2024 earnings that were of -S$32.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$48.28 Million8.59%
2025 -S$44.46 Million36.33%
2024 -S$32.61 Million-15.25%
2023 -S$38.48 Million11.62%
2022 -S$34.48 Million30.84%
2021 -S$26.35 Million15.58%
2020 -S$22.8 Million3.41%
2019 -S$22.05 Million51.16%
2018 -S$14.59 Million40.41%
2017 -S$10.39 Million27.54%
2016 -S$8.15 Million-47.49%
2015 -S$15.51 Million-17.25%
2014 -S$18.75 Million35.91%
2013 -S$13.79 Million112.3%
2012 -S$6.5 Million46.53%
2011 -S$4.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.21 B-69,117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$1.75 B-3,755.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$1.75 B-3,753.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
S$53.29 M-210.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-S$0.13 Billion 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-S$10.03 Million-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA